Navigation Links
Health Outcomes Liaisons Key to Pharmaceutical Sector Navigating Payer-Focused Marketplace
Date:12/7/2012

CHAPEL HILL, N.C., Dec. 7, 2012 /PRNewswire/ -- Managed care organizations and other payer types - including the government sector - have quickly grown into the key customer group for the biopharmaceutical industry. With billions in sales riding on effectively communicating with these organizations regarding products' effectiveness, safety and cost effectiveness, the biopharmaceutical industry has turned to a relatively new function to fill this critical role: Health Outcomes Liaisons (HOLs).

HOLs serve as a scientific bridge between companies and health care system decision-makers in managed care by providing scientific, medical, and pharmacoeconomic support to customers and bringing back feedback to help the company improve products. Some HOLs also have responsibility for conducting pharmacoeconomic and health outcomes research in collaboration with the decision-makers, as well as training colleagues on the importance and uses of outcomes data.

To help executives better navigate this new payer landscape, research and consulting leader Best Practices, LLC conducted a research study to provide benchmarks and insights into how leading companies are delivering exceptional HOL services in an increasingly challenging business environment. "Health Outcomes Liaisons Excellence: How the HOL Function Drives Value Across the Healthcare Industry" is a new, 63-page study that probes the structure, resources and activities of Health Outcome Liaisons (HOL) programs at leading organizations. 

Issues addressed in the study include:

  • Structure and resources of Health Outcome Liaisons (HOL) programs, including staffing, budget, geographic span, oversight responsibility, and services provided   
  • Scope, frequency, and timing of HOL services  
  • Methods HOLs use to engage internal and external customers and build lasting relationships  
  • Differences in roles of HOL, MSL, Key Account Manager and Sales staff  
  • Future trends expected to impact the HOL function   

The research also examines best practices in HOL management and identifies future trends expected to impact the HOL function. Leaders burdened with headcount constraints and insufficient resources to support new products can potentially gain critical efficiencies through the shrewd use of HOLs.

This benchmarking research drew participation from 23 HOL program leaders from 19 different pharmaceutical and medical device companies. In addition, deep-dive interviews were conducted with five participating companies to gather additional insights.

To learn more about this report, download a complimentary report excerpt at http://www3.best-in-class.com/rr1194.htm. For related research, visit our Best Practices, LLC Web site at www.best-in-class.com/

ABOUT BEST PRACTICES, LLC   
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. The operational insights, findings and analysis form the basis for our Benchmarking Reports, databases and advisory services to support executives in commercial and R&D operations.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Aratana to Present at Bank of America Merrill Lynch Animal Health Summit
2. The First Lean Healthcare App is Now Available in Apples App Store
3. Accuray Incorporated to Speak at 23rd Annual Oppenheimer Healthcare Conference
4. Jardogs Strengthens Leadership Team with the Addition of Two Seasoned Healthcare Executives
5. Verizon, Healthsense Bring Home-Health Solutions to a Top Retirement Community in Virginia
6. HeartWare Presentation at the Oppenheimer 23rd Annual Healthcare Conference to be Webcast
7. Suture Express Files Antitrust Lawsuit Against Cardinal Health and Owens & Minor
8. Christiana Care Health System to Provide Free Hip and Knee Replacements, December 6, as Part of Operation Walk USA 2012
9. AMRI Extends Long Term Supply Relationship with GE Healthcare
10. Arena Pharmaceuticals to Present at the Oppenheimer 23rd Annual Healthcare Conference
11. Cempra, Inc. to Present at Oppenheimer 23rd Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... --> --> This press release is ... --> Japan .  --> A separate press release has ... Shire continues to strengthen its presence ... Shire continues to strengthen its presence in ... continues to strengthen its presence in ...
(Date:2/10/2016)... , Feb. 10, 2016  Resolve Therapeutics, ... transformative new approaches to the treatment of lupus ... of a multiple ascending dose study in patients ... compound RSLV-132. --> ... placebo-controlled multiple ascending dose study of RSLV-132 in ...
(Date:2/10/2016)... YORK , Feb. 10, 2016 Immune ... biopharmaceutical company, announced today that it has filed a ... Leukemia and other cancers. --> ... treating cancer by administration of Ceplene (histamine dihydrochloride) in ... provides methods of predicting the efficacy of Ceplene and ...
Breaking Medicine Technology:
(Date:2/11/2016)... ... February 11, 2016 , ... From March 4 through ... Dermatology Annual Meeting at the Walter E. Washington Convention Center in Washington, D.C. ... the condition of hyperhidrosis (excessive sweating) and its treatment options. Specifically, the company ...
(Date:2/11/2016)... Diego, CA (PRWEB) , ... February 11, 2016 , ... ... which was held in San Diego, CA, on February 6th & 7th, 2016 according ... combine for those who were not invited to the NFL’s combine in Indianapolis,” says ...
(Date:2/11/2016)... ... 11, 2016 , ... The book, “Computers Should Just Work!”, provides a basic, ... your IT consultant before signing a contract and how to spot an incompetent or ... relying heavily on e-mail and technology, it’s more important than ever to make sure ...
(Date:2/11/2016)... ... February 11, 2016 , ... As part of their 2015 end of ... Round Table Foundation (MDRTF), has gifted $10,000 to University of Chicago to support ovarian ... Billy Cundiff. , “We are honored to support a promising young investigator from Dr. ...
(Date:2/10/2016)... Culver City, California (PRWEB) , ... February 10, ... ... Molecular Imaging Society (WMIS), known as the World Molecular Imaging Congress (WMIC), will ... The theme for the 2016 meeting is “Imaging Biology…Improving Therapy.” The congress will ...
Breaking Medicine News(10 mins):